In this randomized controlled trial in participants with nonalcoholic fatty liver disease, supplementing with myo-inositol improved most of the insulin resistance metrics evaluated.
This Study Summary was published on November 14, 2024.
In this randomized controlled trial in participants with nonalcoholic fatty liver disease, supplementing with myo-inositol improved most of the insulin resistance metrics evaluated.
This Study Summary was published on November 14, 2024.
